Benavides AJF, Tobón ZGE

Language: Spanish
References: 16
Page: 157-166
PDF size: 341.79 Kb.

ABSTRACT

Introduction: the mineral deficiency in the human population has been associated with metabolic, hormonal and immunological disorders. These minerals are generally supplemented with inorganic salts in the body, but they might cause gastric distress and low absorption problems depending on the type of salt used. Previous studies demonstrated adequate absorption and absence of gastric effects when minerals were associated with organic ligands such as enzymes, proteins and particularly amino acids.
Objective: to determine the viability of copper, magnesium, manganese and zinc asparaginates as nutritional supplements in a preformulation study.
Methods: the synthesis and verification of the formation of complexes were carried out by Fourier transformed infrared spectroscopy and X-ray diffraction of powders. The solubility, the dissociation constant, the dissolution efficiency and the physical solid state properties (morphology, particle distribution and size, Haussner´s index, porosity and compressibility) of these complexes were evaluated. The compatibility of the complex with excipients was determined.
Results: the involvement of the asparagine carboxyl group in the formation of the coordination bond of the complex was observed in the infrared spectra. the absence of starting materials and the crystallinity in the complexes were evidenced in the X-ray diffraction of powders. The solubility, the dissociation constant and the dissolution efficiency of the complexes established their amphoteric character.
Conclusions: the results achieved in the physical solid state properties, the level of moisture and the compatibility with the formulation excipients indicate that copper, magnesium, manganese and zinc asparaginates have suitable rheological properties for pharmaceutical purposes.

REFERENCES

1. Hanikenne M, Merchant S, Hamel P. Transition metal nutrition: a balance between deficiency and toxicity. The Chlamydomonas: organellar and metabolic processes. 2nd ed. Ottawa: David Stern; 2009. p. 333-99.

2. Benavides J, Tobón G. Evaluación de la dimensión fractal reactiva de los glicinatos de magnesio, manganeso y zinc. Rev Cubana Farm [Internet]. 2012 [citada 7 Nov 2012];46(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75152012000100003&lng=es

3. Violante A, Ricciardella M, Pigna M, Capasso R. Effects of organic ligands on the adsorption of trace elements onto metal oxides and organo-mineral complexes. Biogeochemistry of trace elements in the rhizosphere. Amsterdam: Elsiver; 2005. p. 157-82.

4. Benavides J. Evaluación de complejos organometálicos para la suplementación oral [tesis]. Medellín: Universidad de Antioquia; 2012.

5. Wells J. Pharmaceutical preformulation. 2nd ed. London: Horwood; 1993. p. 193-208.

6. Tobón G, Benavides J, Flórez O. Copper glycinate: an approach to its solubility. Rev Cubana Farm [Internet]. 2009 [citada 7 Oct 2012];43(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75152009000100005&lng=es&nrm=iso&tlng=es

7. Barman T, Mukherjee G. Coordination equilibria of mixed ligand complex of CuII with glycylglycine and biguanide. Indian J Chem. 2009;48A:38-44.

8. United States Pharmacopeial Convention. USP 32/NF 27. physical Test and Determinations. The official compendia of standards. Rovkville: Marck Printing; 2000. p. 11, 711, 776, 786, 1181, 2040, 1057-1315.

9. Valores de referencia diarios y nivel de ingesta máximo tolerable de vitaminas, minerales y oligoelementos para suplementos dietarios. Santa Fé de Bogotá, República de Colombia, Ministerio de la Protección Social. Decreto 3249 (2006).

10. Swarbrick J, Boylan J. Encyclopedia of pharmaceutical Technology. Vol. XII Tomo 6. New York: Marcel Dekker; 1997. p. 165.

11. Tobón G, Flórez O, Baena J. Validación de la técnica deaAnálisis del tamaño de partículas por medio de un microscopio de luz óptica asistido por un computador personal. Vitae. 2006;13:85-95.

12. Rowe R, Sheskey P, Owen S. Handbook of pharmaceutical excipients. 5th ed. London: Butler & Tanner; 2006. p. 132, 701, 767.

13. Segment Marketing LAB. AG Laboratory & Weighing Technologies. Artículos técnicos. FarmaNews 5. Greifensee: Ed. Mettler-Toledo; 2007.

14. Baran E, Viera I, Torre M. Vibrational spectra of the Cu (II) complexes of Lasparagine and L-glutamine. Spectrochim Acta A. 2007;66:114-7.

15. Wagner C, Baran E. Vibrational spectra of Zn(II) complex of the amino acids with hydrophobic residues. Spectrochim Acta Part A. 2009;72:936-40.

16. Huang L, Tong W. Impact of solid state properties on develop ability assessment of drug candidates. Adv. Drug Delivery Rev. 2004;56:321-34.